DOCSLIB.ORG

The University of Chicago the Role of H3k79me2 In

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The University of Chicago the Role of H3k79me2 In THE UNIVERSITY OF CHICAGO THE ROLE OF H3K79ME2 IN LEUKEMIA AND ALTERNATIVE SPLICING A DISSERTATION SUBMITTED TO THE FACULTY OF THE DIVISION OF THE BIOLOGICAL SCIENCES AND THE PRITZKER SCHOOL OF MEDICINE IN CANDIDACY FOR THE DEGREE OF DOCTOR OF PHILOSOPHY GRADUATE PROGRAM IN CELL AND MOLECULAR BIOLOGY BY WILLIAM FRANK RICHTER, JR. CHICAGO, ILLINOIS MARCH 2021 Dedicated to my mother, who always supported me in my endeavors and helped spark my interest in science. TABLE OF CONTENTS LIST OF FIGURES ..................................................................................................................... viii LIST OF TABLES .......................................................................................................................... x ACKNOWLEDGEMENTS ........................................................................................................... xi ABSTRACT .................................................................................................................................. xii 1. INTRODUCTION .................................................................................................................. 1 HISTONE POST-TRANSLATIONAL MODIFICATIONS ......................................... 1 DOT1L AND METHYLATION OF LYSINE 79 OF HISTONE H3 ............................ 6 MLL-REARRANGEMENTS AND HISTONE METHYLATION IN LEUKEMIA .. 11 FLT3 LESIONS IN LEUKEMIA ................................................................................. 20 THE ROLES OF HISTONE POST-TRANSLATIONAL MODIFICATIONS IN ALTERNATIVE SPLICING .................................................................................................... 24 NON-CANONICAL PATHWAYS REGULATING GROWTH SIGNALING AND HISTONE METHYLATION MEDIATE THE SENSITIVITY OF MLL-REARRANGED LEUKEMIA TO LOW-DOSE DOT1L INHIBITION ................................................................. 31 INTRODUCTION ........................................................................................................ 31 RESULTS ..................................................................................................................... 34 2.2.1 MLL-r leukemia is sensitive to DOT1L inhibition via a non-canonical pathway .... 34 2.2.2 DOT1L inhibition at low concentrations downregulates leukemic oncogenes ........ 36 iii 2.2.3 MLL-AF4 targets downregulated by low dose DOT1L inhibition are highly enriched for H3K79me2 ...................................................................................................................... 44 2.2.4 MLL-r cells with FLT3-ITD mutations are hypersensitive to both FLT3 and DOT1L inhibition ............................................................................................................................... 50 2.2.5 Reduced FLT3 signaling by DOT1L inhibition culminates in reduced transcription of STAT5A target genes ....................................................................................................... 53 2.2.6 Overexpression of constitutively active STAT5A rescues proliferation and target gene expression defects caused by DOT1L inhibition ......................................................... 57 2.2.7 An ancillary DOT1L-dependent pathway limits proliferation through PRC2 signaling ................................................................................................................................ 61 2.2.8 STAT5A-CA overexpression rescues the viability of MV4;11 cells treated with MLL1 inhibitors .................................................................................................................... 65 DISCUSSION ............................................................................................................... 71 2.3.1 The FLT3-ITD signaling pathway accounts for the bulk of low-dose DOT1L inhibitor toxicity .................................................................................................................... 72 2.3.2 Extensive histone modification cross-talk contributes to the survival of MLL-r, FLT3-ITD+ leukemia ........................................................................................................... 75 2.3.3 Broader Clinical implications ................................................................................... 77 MATERIALS AND METHODS .................................................................................. 78 2.4.1 Accession numbers ................................................................................................... 78 2.4.2 Cell Culture ............................................................................................................... 78 2.4.3 RNA-seq and Gene Expression Analysis ................................................................. 79 2.4.4 Reverse Transcription and Quantitative real-time PCR ............................................ 80 iv 2.4.5 Cell Proliferation Assay ............................................................................................ 80 2.4.6 Apoptosis Assay ....................................................................................................... 80 2.4.7 Calibrated chromatin immunoprecipitation sequencing (ICeChIP-seq) ................... 81 2.4.8 Western blotting ........................................................................................................ 82 2.4.9 Plasmid generation .................................................................................................... 82 2.4.10 Transfection for lentiviral particle generation ...................................................... 83 2.4.11 Lentiviral transduction .......................................................................................... 83 DOT1L INHIBITION IMPACTS ALTERNATIVE SPLICING THROUGH RECRUITMENT OF THE SPLICING FACTOR PTBP1 ........................................................... 84 INTRODUCTION ........................................................................................................ 84 RESULTS ..................................................................................................................... 89 3.2.1 DOT1L inhibition results in greater exon inclusion of alternatively spliced genes . 89 3.2.2 Splicing factors including PTBP1 are enriched in H3K79me2-modified nucleosome pulldowns from nuclear extract ............................................................................................ 92 3.2.3 Pinometostat-induced alternatively spliced genes have aberrantly high H3K79me2 and show stark increases in H3K36me3 upon pinometostat treatment ................................ 94 3.2.4 PTBP1 knockdown reproduces pinometostat-induced effects on alternative splicing and reduces leukemia cell viability ....................................................................................... 99 3.2.5 H3K79me2 depletion results in alternative splicing of the PTEN tumor suppressor, increased PTEN protein levels and reduced AKT signaling .............................................. 101 DISCUSSION ............................................................................................................. 102 3.3.1 H3K79me2 is recognized by splicing factors including PTBP1, and depleting H3K79me2 or PTBP1 results in similar effects on splicing ............................................... 102 v 3.3.2 PTBP1 knockdown decreases MV4;11 MLL-r leukemia viability, consistent with its role in promoting proliferation in other malignancies ........................................................ 105 3.3.3 H3K79me2-regulated alternatively spliced genes have abnormally high H3K79me2 and large pinometostat-induced increases in H3K36me3 ................................................... 106 MATERIALS AND METHODS ................................................................................ 108 3.4.1 Accession numbers ................................................................................................. 108 3.4.2 Cell Culture ............................................................................................................. 108 3.4.3 Reverse Transcription and Quantitative real-time PCR .......................................... 109 3.4.4 Cell Proliferation Assay .......................................................................................... 109 3.4.5 Western blotting ...................................................................................................... 110 3.4.6 Plasmid generation .................................................................................................. 110 3.4.7 Transfection for lentiviral particle generation ........................................................ 110 3.4.8 Lentiviral transduction ............................................................................................ 111 3.4.9 Octamer assembly ................................................................................................... 111 3.4.10 Nucleosome reconstitution .................................................................................. 112 3.4.11 Nuclear extraction ............................................................................................... 112 3.4.12 Nucleosome pulldown ........................................................................................ 113 CONCLUSIONS ................................................................................................................ 115 MANY FUNCTIONS OF H3K79ME LACK MECHANISTIC EXPLANATION .. 115 THE FLT3-ITD/STAT5A SIGNALING PATHWAY IS ACTIVATED
Load more

Recommended publications
  • The Histone Methyltransferase DOT1L Prevents Antigen-Independent
    bioRxiv preprint doi: https://doi.org/10.1101/826255; this version posted November 18, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The histone methyltransferase DOT1L prevents antigen-independent differentiation and safeguards epigenetic identity of CD8+ T cells Eliza Mari Kwesi-Maliepaard1*, Muhammad Assad Aslam2,3*, Mir Farshid Alemdehy2*, Teun van den Brand4, Chelsea McLean1, Hanneke Vlaming1, Tibor van Welsem1, Tessy Korthout1, Cesare Lancini1, Sjoerd Hendriks1, Tomasz Ahrends5, Dieke van Dinther6, Joke M.M. den Haan6, Jannie Borst5, Elzo de Wit4, Fred van Leeuwen1,7,#, and Heinz Jacobs2,# 1Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands 2Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066CX Amsterdam, The Netherlands 3Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, 60800 Multan, Pakistan 4Division of Gene Regulation, Netherlands Cancer Institute, 1066CX Amsterdam, and Oncode Institute, The Netherlands 5Division of Tumor Biology & Immunology, Netherlands Cancer Institute, 1066CX Amsterdam, and Oncode Institute, The Netherlands 6Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Location VUmc, 1081HV Amsterdam, The Netherlands 7Department of Medical Biology, Amsterdam UMC, location AMC, UvA, 1105 AZ Amsterdam, The Netherlands * These authors contributed equally to this work. # Equal contribution and corresponding authors [email protected]; [email protected] Lead contact: Fred van Leeuwen 1 bioRxiv preprint doi: https://doi.org/10.1101/826255; this version posted November 18, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • The Diverse Functions of Dot1 and H3K79 Methylation
    Downloaded from genesdev.cshlp.org on October 8, 2021 - Published by Cold Spring Harbor Laboratory Press REVIEW The diverse functions of Dot1 and H3K79 methylation Anh Tram Nguyen1,2 and Yi Zhang1,2,3 1Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA; 2Department of Biochemistry and Biophysics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA DOT1 (disruptor of telomeric silencing; also called ute to transcriptional regulation is to serve as a platform Kmt4) was initially discovered in budding yeast in a genetic for the recruitment of effector proteins. The well-studied screen for genes whose deletion confers defects in telo- lysine methylation residues include K4, K9, K27, K36, meric silencing. Since the discovery ~10 years ago that and K79 of histone H3, and K20 of histone H4. In general, Dot1 and its mammalian homolog, DOT1L (DOT1-Like), methylation at H3K9, H3K27, and H4K20 correlates with possess histone methyltransferase activity toward histone transcriptional repression, while methylation at H3K4, H3 Lys 79, great progress has been made in characterizing H3K36, and H3K79 correlates with gene transcription their enzymatic activities and the role of Dot1/DOT1L- (Kouzarides 2002; Peterson and Laniel 2004; Martin and mediated H3K79 methylation in transcriptional regula- Zhang 2005). In addition to its role in transcriptional tion, cell cycle regulation, and the DNA damage response. regulation, methylation has also been linked to X inacti- In addition, gene disruption in mice has revealed that vation, cell fate determination, terminal differentiation, mouse DOT1L plays an essential role in embryonic de- and the spatiotemporal patterning of Hox genes (Cavalli velopment, hematopoiesis, cardiac function, and the de- 2006; Minard et al.
    [Show full text]
  • Dynamics of Transcription-Dependent H3k36me3 Marking by the SETD2:IWS1:SPT6 Ternary Complex
    bioRxiv preprint doi: https://doi.org/10.1101/636084; this version posted May 14, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Dynamics of transcription-dependent H3K36me3 marking by the SETD2:IWS1:SPT6 ternary complex Katerina Cermakova1, Eric A. Smith1, Vaclav Veverka2, H. Courtney Hodges1,3,4,* 1 Department of Molecular & Cellular Biology, Center for Precision Environmental Health, and Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, 77030, USA 2 Institute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague, Czech Republic 3 Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA 4 Department of Bioengineering, Rice University, Houston, TX, 77005, USA * Lead contact; Correspondence to: [email protected] Abstract The genome-wide distribution of H3K36me3 is maintained SETD2 contributes to gene expression by marking gene through various mechanisms. In human cells, H3K36 is bodies with H3K36me3, which is thought to assist in the mono- and di-methylated by eight distinct histone concentration of transcription machinery at the small portion methyltransferases; however, the predominant writer of the of the coding genome. Despite extensive genome-wide data trimethyl mark on H3K36 is SETD21,11,12. Interestingly, revealing the precise localization of H3K36me3 over gene SETD2 is a major tumor suppressor in clear cell renal cell bodies, the physical basis for the accumulation, carcinoma13, breast cancer14, bladder cancer15, and acute maintenance, and sharp borders of H3K36me3 over these lymphoblastic leukemias16–18. In these settings, mutations sites remains rudimentary.
    [Show full text]
  • 16-0368 Technical Data Sheet
    Nucleosome, Recombinant Human, H3K79me2 dNuc, Biotinylated Catalog No. 16-0368 Lot No. 19045001 Pack Size 50 µg Product Description: 1 2 Mononucleosomes assembled from recombinant human histones expressed in E. coli (two each of histones H2A, H2B, H3 and H4; accession numbers: H2A-P04908; H2B- O60814; H3.1-P68431; H4-P62805) wrapped by 147 base pairs of 601 positioning sequence DNA. Histone H3 (created by a proprietary synthetic method) contains dimethyl-lysine at position 79. The nucleosome is the basic subunit of chromatin. The 601 sequence, identified by Lowary and Widom, is a 147-base pair sequece that has high affinity for histone octamers and is useful for nucleosome assembly and contains a 5’ biotin-TEG group. Western Blot Data: Western Analysis of Nucleosome, Recombinant Human, H3K79me2. Top Panel: Unmodified H3 Formulation: (Lane 1) and H3K79me2 containing nucleosomes (Lane 2) were Nucleosome, Recombinant Human, H3K79me2 (27.3 µg probed with an anti-H3K79me2 antibody and analyzed via ECL protein weight, 50 µg total weight) in µl of 10 mM Tris readout. Only the H3K79me2sample produced a detectable signal. HCl, pH 7.5, 25 mM NaCl, 1 mM EDTA, 2 mM DTT, 20% Bottom Panel: Detailfrom Coomassie stained gel showing glycerol. unmodified nucleosomes (Lane 1) and H3K79me2 nucleosomes Molarity = μmolar. MW = Da. (Lane 2). Storage and Stability: Stable for six months at -80°C from date of receipt. For best results, aliquot and avoid multiple freeze/thaws. Application Notes: Nucleosome, Recombinant Human, H3K79me2 dNucs are highly purified and are suitable for use as substrates in enzyme screening assays or for effector protein binding experiments.
    [Show full text]
  • Le G´Enome En Action
    LEGENOME´ EN ACTION SEQUENC´ ¸ AGE HAUT DEBIT´ ET EPIG´ ENOMIQUE´ Epig´enomique´ ? IFT6299 H2014 ? UdeM ? Mikl´osCs}ur¨os Regulation´ d’expression la transcription d’une region´ de l’ADN necessite´ ? liaisons proteine-ADN´ (facteur de transcription et son site reconnu) ? accessibilite´ de la chromatine REVIEWS Identification of regions that control transcription An initial step in the analysis of any gene is the identifi- cation of larger regions that might harbour regulatory control elements. Several advances have facilitated the prediction of such regions in the absence of knowl- edge about the specific characteristics of individual cis- Chromatin regulatory elements. These tools broadly fall into two categories: promoter (transcription start site; TSS) and enhancer detection. The methods are influenced Distal TFBS by sequence conservation between ORTHOLOGOUS genes (PHYLOGENETIC FOOTPRINTING), nucleotide composition and the assessment of available transcript data. Functional regulatory regions that control transcrip- tion rates tend to be proximal to the initiation site(s) of transcription. Although there is some circularity in the Co-activator complex data-collection process (regulatory sequences are sought near TSSs and are therefore found most often in these regions), the current set of laboratory-annotated regula- tory sequences indicates that sequences near a TSS are Transcription more likely to contain functionally important regulatory initiation complex Transcription controls than those that are more distal. However, specifi- initiation cation of the position of a TSS can be difficult. This is fur- ther complicated by the growing number of genes that CRM Proximal TFBS selectively use alternative start sites in certain contexts. Underlying most algorithms for promoter prediction is a Figure 1 | Components of transcriptional regulation.
    [Show full text]
  • Modeling Circrnas Expression Pattern with Integrated Sequence And
    bioRxiv preprint doi: https://doi.org/10.1101/392019; this version posted August 15, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Modeling circRNAs expression pattern with integrated sequence and 2 epigenetic features identifies H3K79me2 as regulators for circRNAs 3 expression 4 Jia-Bin Chen1#, Shan-Shan Dong1#, Shi Yao1, Yuan-Yuan Duan1, Wei-Xin Hu1, Hao 5 Chen1, Nai-Ning Wang1, Ruo-Han Hao1, Ming-Rui Guo1, Yu-Jie Zhang1, Yu Rong1, Yi- 6 Xiao Chen1, Hlaing Nwe Thynn1, Fu-Ling Zhou2, Yan Guo1*, Tie-Lin Yang1* 7 8 Running title: Exploring circRNAs expression regulatory mechanism 9 10 1Key Laboratory of Biomedical Information Engineering of Ministry of Education, 11 School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P. R. 12 China 13 2Department of Hematopathology, Zhongnan Hospital of Wuhan University, Wuhan 14 430071, P. R. China 15 16 #These authors contribute equally to this work. 17 The authors wish it to be known that, in their opinion, the first 2 authors should be 18 regarded as joint First Authors 19 20 *Corresponding Authors: 21 Tie-Lin Yang, Ph.D. 22 Key Laboratory of Biomedical Information Engineering of Ministry of Education, 23 School of Life Science and Technology, Xi'an Jiaotong University, Xi'an 710049, P. R. 24 China 25 Tel: 86-29-82668463 1 bioRxiv preprint doi: https://doi.org/10.1101/392019; this version posted August 15, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder.
    [Show full text]
  • Synthetic Histone Code
    Available online at www.sciencedirect.com ScienceDirect Synthetic histone code 1 2 3 Wolfgang Fischle , Henning D Mootz and Dirk Schwarzer Chromatin is the universal template of genetic information in all copies each of the core histones H2A, H2B, H3, and H4 eukaryotic cells. This complex of DNA and histone proteins not and one copy of linker histone H1, Figure 1a) [1]. By only packages and organizes genomes but also regulates gene various levels of folding, the originating primary chroma- expression. A multitude of posttranslational histone tin fiber can be organized into various structural arrange- modifications and their combinations are thought to constitute ments, including highly condensed mitotic chromosomes a code for directing distinct structural and functional states of (Figure 1b). While the basic architecture of nucleosomes chromatin. Methods of protein chemistry, including protein is the same throughout the genome, posttranslational semisynthesis, amber suppression technology, and cysteine modifications (PTMs) of histones are central means of bioconjugation, have enabled the generation of so-called increasing the biochemical divergence that regulates designer chromatin containing histones in defined and chromatin structure and function [2,3]. Histone PTMs homogeneous modification states. Several of these are structurally diverse and include methylation, acetyla- approaches have matured from proof-of-concept studies into tion and ubiquitinylation of lysine, as well as phosphor- efficient tools and technologies for studying the biochemistry of ylation of serine and threonine residues (Figure 1c). More chromatin regulation and for interrogating the histone code. We than 150 histone modification sites have been identified summarize pioneering experiments and recent developments in different experimental systems.
    [Show full text]
  • A Systematic Benchmark of Nanopore Long Read RNA Sequencing for Transcript Level Analysis in Human Cell Lines
    bioRxiv preprint doi: https://doi.org/10.1101/2021.04.21.440736; this version posted April 22, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. A systematic benchmark of Nanopore long read RNA sequencing for transcript level analysis in human cell lines Authors: Ying Chen1, Nadia M. Davidson2,3, Yuk Kei Wan1, Harshil Patel4, Fei Yao1, Hwee Meng Low1, Christopher Hendra1,5, Laura Watten1, Andre Sim1, Chelsea Sawyer4, Viktoriia Iakovleva1,6, Puay Leng Lee1, Lixia Xin1, Hui En Vanessa Ng7, Jia Min Loo1, Xuewen Ong8, Hui Qi Amanda Ng1, Jiaxu Wang1, Wei Qian Casslynn Koh1, Suk Yeah Polly Poon1, Dominik Stanojevic1,9, Hoang-Dai Tran1, Kok Hao Edwin Lim1, Shen Yon Toh10, Philip Andrew Ewels11, Huck-Hui Ng1, N.Gopalakrishna Iyer10,12, Alexandre Thiery13, Wee Joo Chng6,7,14, Leilei Chen7,15, Ramanuj DasGupta1, Mile Sikic1,9, Yun-Shen Chan1, Boon Ooi Patrick Tan1,7,8, Yue Wan1, Wai Leong Tam1,7,16,17, Qiang Yu1, Chiea Chuan Khor1,12,18, Torsten Wüstefeld1,10,14, Ploy N. Pratanwanich1,19,20, Michael I. Love21,22, Wee Siong Sho Goh1, 23, Sarah B. Ng1, Alicia Oshlack2,24, Jonathan Göke1,10*, SG-NEx consortium Affiliations: 1.Genome Institute of Singapore, Singapore, Singapore 2.Peter MacCallum Cancer Centre, Melbourne, VIC, Australia 3.School of BioSciences, The University of Melbourne, Parkville, Victoria, Australia 4.Bioinformatics and Biostatistics, The
    [Show full text]
  • Chromatin Poises Mirna- and Protein-Coding Genes for Expression
    Downloaded from genome.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Letter Chromatin poises miRNA- and protein-coding genes for expression Artem Barski,1,2 Raja Jothi,1,2,3 Suresh Cuddapah,1,2 Kairong Cui,1 Tae-Young Roh,1,4 Dustin E. Schones,1 and Keji Zhao1,5 1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA Chromatin modifications have been implicated in the regulation of gene expression. While association of certain mod- ifications with expressed or silent genes has been established, it remains unclear how changes in chromatin environment relate to changes in gene expression. In this article, we used ChIP-seq (chromatin immunoprecipitation with massively parallel sequencing) to analyze the genome-wide changes in chromatin modifications during activation of total human CD4+ T cells by T-cell receptor (TCR) signaling. Surprisingly, we found that the chromatin modification patterns at many induced and silenced genes are relatively stable during the short-term activation of resting T cells. Active chromatin modifications were already in place for a majority of inducible protein-coding genes, even while the genes were silent in resting cells. Similarly, genes that were silenced upon T-cell activation retained positive chromatin modifications even after being silenced. To investigate if these observations are also valid for miRNA-coding genes, we systematically identified promoters for known miRNA genes using epigenetic marks and profiled their expression patterns using deep sequencing. We found that chromatin modifications can poise miRNA-coding genes as well. Our data suggest that miRNA- and protein-coding genes share similar mechanisms of regulation by chromatin modifications, which poise inducible genes for activation in response to environmental stimuli.
    [Show full text]
  • S41467-017-02759-8.Pdf
    ARTICLE DOI: 10.1038/s41467-017-02759-8 OPEN Dot1 regulates nucleosome dynamics by its inherent histone chaperone activity in yeast Soyun Lee1, Seunghee Oh1, Kwiwan Jeong2, Hyelim Jo1, Yoonjung Choi1, Hogyu David Seo1, Minhoo Kim1, Joonho Choe1, Chang Seob Kwon3 & Daeyoup Lee1 Dot1 (disruptor of telomeric silencing-1, DOT1L in humans) is the only known enzyme responsible for histone H3 lysine 79 methylation (H3K79me) and is evolutionarily conserved 1234567890():,; in most eukaryotes. Yeast Dot1p lacks a SET domain and does not methylate free histones and thus may have different actions with respect to other histone methyltransferases. Here we show that Dot1p displays histone chaperone activity and regulates nucleosome dynamics via histone exchange in yeast. We show that a methylation-independent function of Dot1p is required for the cryptic transcription within transcribed regions seen following disruption of the Set2–Rpd3S pathway. Dot1p can assemble core histones to nucleosomes and facilitate ATP-dependent chromatin-remodeling activity through its nucleosome-binding domain, in vitro. Global analysis indicates that Dot1p appears to be particularly important for histone exchange and chromatin accessibility on the transcribed regions of long-length genes. Our findings collectively suggest that Dot1p-mediated histone chaperone activity controls nucleosome dynamics in transcribed regions. 1 Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon 34141, Republic of Korea. 2 Biocenter, Gyeonggi Business
    [Show full text]
  • Histone H3 (Di-Methyl K79) Quantification Kit (Fluorometric)
    ab115086 – Histone H3 (di-methyl K79) Quantification Kit (Fluorometric) Instructions for Use For the measurement of global H3K79me2 This product is for research use only and is not intended for diagnostic use. Version 1a Last Updated 22 February 2019 Table of Contents INTRODUCTION 1. BACKGROUND 2 2. ASSAY SUMMARY 3 GENERAL INFORMATION 3. PRECAUTIONS 4 4. STORAGE AND STABILITY 4 5. MATERIALS SUPPLIED 5 6. MATERIALS REQUIRED, NOT SUPPLIED 5 7. LIMITATIONS 6 8. TECHNICAL HINTS 6 ASSAY PREPARATION 9. REAGENT PREPARATION 7 10. SAMPLE PREPARATION 7 ASSAY PROCEDURE 11. ASSAY PROCEDURE 9 DATA ANALYSIS 12. ANALYSIS 10 RESOURCES 13. TROUBLESHOOTING 11 14. NOTES 12 Discover more at www.abcam.com 1 INTRODUCTION 1. BACKGROUND Epigenetic activation or inactivation of genes plays a critical role in many important human diseases, especially in cancer. A major mechanism for epigenetic inactivation of the genes is methylation of CpG islands in genome DNA caused by DNA methyltransferases. Histone methyltransferases (HMTs) control or regulate DNA methylation through chromatin-dependent transcription repression or activation. HMTs transfer 1-3 methyl groups from S-adenosyl-L-methionine to the lysine and arginine residues of histone proteins. Dot1 is a histone methyltransferase that catalyzes methylation of histone H3 at lysine 79 (H3K79) in mammalian cells. H3K79 di-methylation is a widespread histone modification and is associated with transcriptionally active genes. Increased global H3K79 di-methylation is also found to be involved in some pathological processes such as leukemogenesis in human. The global H3K79 di-methylation can also be changed by inhibition or activation of HMTs. Thus, quantitative detection of global H3K79me2 would provide useful information for better understanding epigenetic regulation of gene activation and for developing HMT-targeted drugs.
    [Show full text]
  • SETDB1 Mediated Histone H3 Lysine 9 Methylation Suppresses MLL-Fusion Target Expression and Leukemic Transformation
    Acute Myeloid Leukemia SUPPLEMENTARY APPENDIX SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation James Ropa, 1,2 Nirmalya Saha, 1* Hsiangyu Hu, 1* Luke F. Peterson, 3 Moshe Talpaz 3 and Andrew G. Muntean 1 1Department of Pathology, University of Michigan Medical School; 2Department of Computational Medicine and Bioinformatics, Univer - sity of Michigan Medical School and 3Department of Internal Medicine/Division of Hematology/Oncology, University of Michigan School of Medicine and Comprehensive Cancer Center, Ann Abor, MI, USA *NS and HH contributed equally as co-second authors. ©2020 Ferrata Storti Foundation. This is an open-access paper. doi:10.3324/haematol. 2019.223883 Received: April 4, 2019. Accepted: September 25, 2019. Pre-published: September 26, 2019. Correspondence: ANDREW G. MUNTEAN - [email protected] Supplemental Methods and Figures Leukemia colony formation assay Cells were retrovirally transduced as described above. They were then seeded at a density of 1x103 cells in 2mL semi-solid methylcellulose medium for mouse cells (STEMCELL M3234) containing selection antibiotics (1mg/mL G418 and 1ug/mL puromycin or 100ug/mL hygromycin), 10 ng/mL IL-3, GM-CSF, and IL-6 and 100ng/uL SCF (R&D). Colonies were counted, pooled, and replated in the same way for two additional rounds of colony formation and counting. 1x images of the 5-phenyl tetrazolium chloride (INT) stained dishes were taken after round 2. HSPC colony formation Mouse bone marrow was harvested and lineage depletion was performed using the Hematopoeitic Progenitor Isolation Kit (STEMCELL) or CD34+ cells were isolated from mobilized blood. One group of mouse cells were transduced with shRNA against SETDB1 as previously described.
    [Show full text]